NasdaqGS:CRVL

Stock Analysis Report

NOT FOR DISTRIBUTION
Header cover image

Executive Summary

CorVel Corporation provides workers’ compensation solutions for employers, third party administrators, insurance companies, and government agencies seeking to control costs and promote positive outcomes. More Details


Snowflake Analysis

Flawless balance sheet with acceptable track record.


Similar Companies

Share Price & News

How has CorVel's share price performed over time and what events caused price changes?


Latest Share Price and Events

Stable Share Price: CRVL has not had significant price volatility in the past 3 months.


Market Performance


7 Day Return

0.2%

CRVL

0.9%

US Healthcare

-1.1%

US Market


1 Year Return

15.5%

CRVL

17.9%

US Healthcare

15.6%

US Market

Return vs Industry: CRVL underperformed the US Healthcare industry which returned 17.9% over the past year.

Return vs Market: CRVL matched the US Market which returned 15.6% over the past year.


Shareholder returns

CRVLIndustryMarket
7 Day0.2%0.9%-1.1%
30 Day10.6%8.6%4.2%
90 Day16.2%3.5%6.3%
1 Year15.5%15.5%19.4%17.9%18.2%15.6%
3 Year53.2%53.2%35.3%29.6%39.6%30.4%
5 Year167.7%167.7%62.5%50.6%79.5%59.2%

Price Volatility Vs. Market

How volatile is CorVel's share price compared to the market and industry in the last 5 years?


Simply Wall St News

Valuation

Is CorVel undervalued compared to its fair value and its price relative to the market?

39.54x

Price to Earnings (PE) ratio


Share Price vs. Fair Value

Below Fair Value: CRVL ($91.89) is trading above our estimate of fair value ($33.66)

Significantly Below Fair Value: CRVL is trading above our estimate of fair value.


Price To Earnings Ratio

PE vs Industry: CRVL is poor value based on its PE Ratio (39.5x) compared to the US Healthcare industry average (23.3x).

PE vs Market: CRVL is poor value based on its PE Ratio (39.5x) compared to the US market (18.9x).


Price to Earnings Growth Ratio

PEG Ratio: Insufficient data to calculate CRVL's PEG Ratio to determine if it is good value.


Price to Book Ratio

PB vs Industry: CRVL is overvalued based on its PB Ratio (8.3x) compared to the US Healthcare industry average (3.2x).


Next Steps

Future Growth

How is CorVel forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?

13.5%

Forecasted Healthcare industry annual growth in earnings


In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as CorVel has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.


Next Steps

Past Performance

How has CorVel performed over the past 5 years?

13.7%

Historical annual earnings growth


Earnings and Revenue History

Quality Earnings: CRVL has high quality earnings.

Growing Profit Margin: CRVL's current net profit margins (7.4%) are lower than last year (8.1%).


Past Earnings Growth Analysis

Earnings Trend: CRVL's earnings have grown by 13.7% per year over the past 5 years.

Accelerating Growth: CRVL's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.

Earnings vs Industry: CRVL had negative earnings growth (-12.5%) over the past year, making it difficult to compare to the Healthcare industry average (31.2%).


Return on Equity

High ROE: CRVL's Return on Equity (21.3%) is considered high.


Next Steps

Financial Health

How is CorVel's financial position?


Financial Position Analysis

Short Term Liabilities: CRVL's short term assets ($224.4M) exceed its short term liabilities ($138.5M).

Long Term Liabilities: CRVL's short term assets ($224.4M) exceed its long term liabilities ($88.4M).


Debt to Equity History and Analysis

Debt Level: CRVL is debt free.

Reducing Debt: CRVL has not had any debt for past 5 years.

Debt Coverage: CRVL has no debt, therefore it does not need to be covered by operating cash flow.

Interest Coverage: CRVL has no debt, therefore coverage of interest payments is not a concern.


Balance Sheet


Next Steps

Dividend

What is CorVel current dividend yield, its reliability and sustainability?


Dividend Yield vs Market

Notable Dividend: Unable to evaluate CRVL's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.

High Dividend: Unable to evaluate CRVL's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.


Stability and Growth of Payments

Stable Dividend: Insufficient data to determine if CRVL's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if CRVL's dividend payments have been increasing.


Current Payout to Shareholders

Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.


Future Payout to Shareholders

Future Dividend Coverage: No need to calculate the sustainability of CRVL's dividend in 3 years as they are not forecast to pay a notable one for the US market.


Next Steps

Management

How experienced are the management team and are they aligned to shareholders interests?

4.2yrs

Average management tenure


CEO

Michael Combs (56 yo)

1.75yrs

Tenure

US$1,432,053

Compensation

Mr. Michael G. Combs has been as the President of CorVel Corporation since April 1, 2017 and has been its Chief Executive Officer since January 18, 2019. Mr. Combs Chief Information Officer at CorVel Corp ...


CEO Compensation Analysis

Compensation vs Market: Michael's total compensation ($USD1.43M) is below average for companies of similar size in the US market ($USD4.48M).

Compensation vs Earnings: Michael's compensation has been consistent with company performance over the past year.


Leadership Team

NamePositionTenureCompensationOwnership
Victor Clemons
Chairman & COO29.5yrsUS$401.71k8.87%
$ 146.2m
Michael Combs
President & CEO1.75yrsUS$1.43m0.021%
$ 349.5k
Brandon O'Brien
Chief Financial Officer2yrsUS$512.62k0.0071%
$ 117.3k
Jennifer Yoss
Vice President of Accounting6.33yrsUS$275.14k0.0011%
$ 18.8k
Maxim Shishin
Chief Information Officer3.5yrsUS$596.59k0%
$ 0
Diane Blaha
Chief Marketing Officer3.92yrsUS$625.10k0.028%
$ 468.5k
Stefani Wendel
Investor Relationno datano datano data
Sharon O'Connor
Vice President of Legal & Human Resources4.5yrsno datano data
Richard Schweppe
Secretary25.33yrsUS$223.00kno data

4.2yrs

Average Tenure

56yo

Average Age

Experienced Management: CRVL's management team is considered experienced (4.2 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
Victor Clemons
Chairman & COO29.5yrsUS$401.71k8.87%
$ 146.2m
Steven Hamerslag
Independent Director29.42yrsUS$91.70k0.74%
$ 12.2m
Jeffrey Michael
Independent Director30.08yrsUS$87.70k1.15%
$ 18.9m
R. Jessup
Lead Independent Directorno dataUS$99.70k0.35%
$ 5.7m
Alan Hoops
Independent Director17.42yrsUS$91.70k0.28%
$ 4.7m
Jean Macino
Independent Director12.67yrsUS$88.70k0.067%
$ 1.1m

29.4yrs

Average Tenure

72yo

Average Age

Experienced Board: CRVL's board of directors are seasoned and experienced ( 29.4 years average tenure).


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: CRVL insiders have only sold shares in the past 3 months.


Recent Insider Transactions

Ownership Breakdown

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Company Information

CorVel Corporation's company bio, employee growth, exchange listings and data sources


Key Information

  • Name: CorVel Corporation
  • Ticker: CRVL
  • Exchange: NasdaqGS
  • Founded: 1987
  • Industry: Health Care Services
  • Sector: Healthcare
  • Market Cap: US$1.648b
  • Shares outstanding: 17.93m
  • Website: https://www.corvel.com

Number of Employees


Location

  • CorVel Corporation
  • 1920 Main Street
  • Suite 900
  • Irvine
  • California
  • 92614
  • United States

Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
CRVLNasdaqGS (Nasdaq Global Select)YesCommon StockUSUSDJun 1991

Biography

CorVel Corporation provides workers’ compensation solutions for employers, third party administrators, insurance companies, and government agencies seeking to control costs and promote positive outcomes. I ...


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2020/10/27 00:42
End of Day Share Price2020/10/26 00:00
Earnings2020/06/30
Annual Earnings2020/03/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.